Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Piper Sandler Conf?

<< Previous

Bullboard Posts

Next >>

Comment by qwerty22on Dec 02, 2020 11:30am

123 Views

Post# 32018004

RE:Piper Sandler Conf?

It happened a week ago, you listened to it.

Wino115 wrote: Anyone listen in on THTX at the conf either yesterday or today? Maybe THTX will post a link. Will be interesting to hear if they continue to evolve positively in how they talk about the pipeline. Practice makes perfect in that regard. Not sure we'll hear anything new, but just wanted to know if anyone listened in and picked up anything.

<< Previous

Bullboard Posts

Next >>

Level up your trading with BMO InvestorLine’s enhanced features